Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...

Current guidelines do not specify the ideal timing between standard TURBT, neoadjuvant chemotherapy, and radical cystectomy in patients with muscle-invasive bladder cancer.

The subtypes investigated in bladder cancer were CK19 ... suggests that it can be utilized as surrogate for quality of resection. Intraoperative frozen biopsy and sentinel lymph nodes technique ...

Rezum’ peeing freely ...

If you experience frequent, loose, and bloody stools for more than 4 weeks, it could be a sign of chronic bowel disease, ...

Investigators quantified the risks for complications after cancer surgery in patients who had recently smoked to better understand the trade-offs of delaying surgery.

Keytruda is already approved for adjuvant treatment after resection and platinum-based ... in resectable stage IIA to IIIB NSCLC cases. Bladder cancer hopes back on track There was better news ...

The department of urology at Himchan General Hospital in Incheon introduced nitinol stent insertion, also known as 'itind' ...

Phase III POTOMAC trial showed that adding Durvalumab (Imfinzi) to BCG induction and maintenance therapy significantly ...

A new study contradicts previous research that suggests transurethral resection of the prostate ... indicate prostatic bladder outlet obstruction,” Kessler concludes.

AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the drug demonstrated benefits in those with a higher-risk form of non ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from ...